Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

GastroIntestinal Bleeding clinical trials

3 of 5 indexed GastroIntestinal Bleeding trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

GastroIntestinal Bleeding: 5 US clinical trials tracked, 3 recruiting.

GastroIntestinal Bleeding is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Christopher Marshall, running 1 of these trials.

Enrollment posture brief

Registry condition gastrointestinal-bleeding

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%GastroIntestinal Bleedin (th…60%
Open-enrollment share among volume-matched conditions near GastroIntestinal Bleeding

GastroIntestinal Bleeding lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for GastroIntestinal Bleeding on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. GastroIntestinal Bleeding is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates GastroIntestinal Bleeding research.

    Christopher Marshall accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical GastroIntestinal Bleeding enrolment sits around 100 participants.

    Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. GastroIntestinal Bleeding research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on GastroIntestinal Bleeding records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

No airway intervention Other
1 trials
Endotracheal intubation Other
1 trials
Video Capsule Endoscopy Device
1 trials
Standard of Care Ulcer Treatment (typically PPI Administration) Other
1 trials
Low Thermal Plasma (LTP) Treatment Procedure
1 trials

US sites by state

Facility locations filed on GastroIntestinal Bleeding trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
Texas 2 trials
Pennsylvania 2 trials
Utah 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this GastroIntestinal Bleeding page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 GastroIntestinal Bleeding trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Christopher Marshall sponsors the most GastroIntestinal Bleeding trials on record, review their full trial history before evaluating a specific study. See Christopher Marshall's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This GastroIntestinal Bleeding condition card totals 5 registered trials; most-linked intervention No airway intervention; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.